The NHS is spending £10,694,902 in taxpayer funds on a “clinical trial” at King’s College London, to inject 250 children aged 10-15 who have gender dysphoria with irreversible puberty blockers
This is after the High Court upheld a government ban on puberty blockers, following the Cass Review.
Puberty blockers are coming back.
For those who don't know: this is how Tavistock implemented puberty blockers as clinical "best practice" back in 2014.
Puberty blockers were introduced to Tavistock's GIDS clinic following the publication of the Dutch protocol in 2000 and Dutch study in 2006
The study was funded by Ferring Pharmaceuticals, who produce the puberty blocker Triptorelin — the primary drug prescribed by pediatric endocrinologists at GIDS.
The study followed 70 children prescribed puberty blockers, then cross-sex hormones. Interim results were published in 2011, and final findings in 2014. Between the two publications, before long-term results were published, the protocol authors consistently pushed for universal adoption of puberty blockers.
In 2010, interim results reported that use of puberty blockers had decreased depressive symptoms, but not alleviated gender dysphoria.
All 70 participants (37 females and 33 males) prescribed blockers went on to take cross-sex hormones.
By the 2014 publication, the sample size had shrunk from 70 to 55 — losing more than 20% of participants.
One participant's findings were omitted from the final study: an 18-year-old male who underwent a vaginoplasty, and died of necrotizing fasciitis on the operating table, because the puberty blockers led to his genitals being too underdeveloped for the procedure. This significant mortality rate of 1 in 70 was not reported.
In 2005, British Society of Paediatric Endocrinology and Diabetes policy was to oppose puberty blockers and the Dutch protocol.
But the Gender Identity Research and Education Society and Marmaids organised a conference to develop parallel “guidelines for endocrinological intervention”. They invited the authors of the Dutch protocol to meet with GIDS’ founding director Dr. Domenico Di Ceglie and his successor Dr. Polly Carmichael.
Carmichael kept regular correspondence with Mermaids' Susie Green while running Tavistock.
In 2011, after receiving preliminary results from just 30 participants by the Dutch team, and before even the interim findings were published, GIDS and endocrinologists at University College London Hospitals NHS Foundation Trust started giving puberty blockers to gender-distressed children aged 12 and over.
It was a study very similar to the one being run by the NHS and Kings College London now.
After only the three year interim report, in 2014, GIDS began prescribing puberty blockers, and moved from an “age” to “stage” approach: allowing children to be prescribed blockers at Tanner Stage 2, the initial onset of puberty.
So before the final report was published, puberty blockers became the go-to treatment at Tavistock.
Before the interim report was even published, while only 23 children were part of the study, Carmichael told the Sunday Times in 2013 that she “planned to continue the program indefinitely.”
Carmichael confirmed in an interview with the Mail on Sunday in 2014 that “We’re talking about stopping puberty in the normal range of puberty, so I guess the younger age might be ten or nine.”
Director Sarah Davidson referred patients after only one or two appointments.
Whistleblower Anna Hutchinson notes one case where, within 20 minutes of the first appointment, her colleague offered the adolescent a referral to UCLH for puberty blockers.
Another whistleblower, Anastassis Spiliadis saw a child from a family with a history of domestic and sexual abuse, who said “My mum wants the blocker more than I do.” Despite raising safeguarding concerns, Carmichael suggested that the child be referred for puberty blockers.
When the interim results of the Early Intervention study were presented to the Tavistock board in 2015, one year after puberty blockers had already been adopted as best practice at the clinic, findings for only 30 of the 44 participants (16 females and 14 males) were presented.
Like the Dutch study, almost half the Early Intervention cohort was lost before follow-up. The study also did not use a control group.
Just like the Dutch study, the only thing being measured was how effective puberty blockers were in blocking puberty, with the presumption that this would alleviate gender dysphoria. This was shoddy scholarship, to say the least.
After one year of puberty blockers, researchers reported a statistically significant increase in children agreeing with the statement “I deliberately try to hurt or kill myself” and worsening mental health across the board for adolescent girls.
By mid 2016, all but one of the children in the Early Intervention study had progressed to taking cross-sex hormones. (Just like in the Dutch study.)
The full results of the final study were provided in December 2020 — after Tavistock had failed to procure them when asked in October, and the day following three High Court judges ruling that under-16s could not give informed consent to puberty blockers.
Carmichael knew all this, and pushed blockers en masse anyway:
At an international conference in 2016, Carmichael explained that children’s gender dysphoria and general mental health had either plateaued or worsened while taking blockers.
There was “no change in self-harming thoughts or behaviours … gender identity or gender dysphoric feelings … [or] perception on primary or secondary bodily characteristics”. Carmichael said: “our results have been different to the Dutch … we haven’t seen any change in terms of psychological well-being.”
Just like today, even after the Cass Review, the testimonies of detransitioners like Chloe Cole, Kiera Bell, and Ritchie Herron, the thousands of children robbed of a chance to have a family, the thousands of parents robbed of their children...
They know what they are doing to these children, and they do it anyway. They knew the side effects back in 2016, and they still pushed puberty blockers and hid evidence from the courts, inquiries, and the press.
These people are evil. They are trying to do all they can to bring puberty blockers back. They will use the interim stage of this trial to push for puberty blockers to become clinical "best practice" again.
There is no trial that will change the fact that human beings cannot change sex. Stop experimenting on children for your delusional ideology.
End this trial now.